CNS Tumor Classification on PBT benchmark leaderboard · SOTA2 Research

CNS Tumor Classification on PBT

60Ependymoma F1CLAM

Evaluation Results

Method	Links
CLAM2026.03		60	60	60	75.3	82.4	78	86.4	84.7	85.2	89.7	80	82.4	77.8	76.8	76.4
EF_W2026.03		60	60	60	85.2	90.1	87.3	79	80.7	78.7	87.5	75	79	77.9	76.5	76.2
PM-EF_WTG2026.03		60	60	60	91.1	92.3	91.4	80.2	85.7	82.1	93.5	82.5	86.2	81.2	80.1	79.9
Early Fusion2026.05		60	—	—	—	—	84.4	—	—	74.2	—	—	73.2	74.6	73.5	72.9
PathMoE2026.05		60	—	—	—	—	91.4	—	—	82.1	—	—	86.2	81.2	80.1	79.9
ConceptM3oE2026.05		60	—	—	—	—	88.4	—	—	82.1	—	—	78.7	78.2	76.5	77.3
MambaMIL2026.03		55	53.3	60	75.1	83.8	78.2	85.8	86.8	85.7	89.7	67.5	74.1	76	74.5	73.3
S4MIL2026.03		50	50	50	75.1	82.4	77.4	85.3	88	86.1	81.7	65	71.2	73	71.3	71.2
PM-EF_WT2026.03		50	50	50	90.3	87.8	88.1	78.4	85.7	80.3	92.2	85	86.8	77.7	77.1	76.3
PM-SG_WTG2026.03		50	50	50	87.8	86.9	86.9	75.5	85.7	78.9	92.5	75	81.1	76.4	74.4	74.2
TransMIL2026.03		46.7	45	50	78.2	80.5	76.5	82.4	86.9	82.9	93	62.5	70.2	74.6	70	69.1
PM-SG_WG2026.03		40	40	40	86.5	90.2	87.8	74.6	89	80	98	65	75.3	74.8	71.1	70.8
MoEPP2026.05		40	—	—	—	—	86.4	—	—	79.2	—	—	73.7	72.8	70.3	69.8
PM-EF_WG2026.03		36.7	35	40	85	90.1	87.2	75.9	85.7	79.6	88.3	65	72.8	71.1	70.2	69.1
PM-SG_WT2026.03		30	30	30	86.6	88	86.6	75.2	89	80.7	97.5	75	83.7	72.3	70.5	70.3
Switch Gate2026.05		20	—	—	—	—	85.9	—	—	77.5	—	—	77.3	67.3	66.2	65.2
SG_W2026.03		10	10	10	85.7	85.8	84.8	71.1	89	78	90.8	65	74.6	64.4	62.5	61.8